Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,070 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
最新の財務諸表(Form-10K)によると、Premium Beverage Group Incの総資産は$0で、純손실は$0です。
HOLXの主要な財務比率は何ですか?
Premium Beverage Group Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Hologic Incの収益はセグメントまたは地域別にどのように分けられていますか?
Premium Beverage Group Inc 주요 수익원은 Marine Technology이며, 최신 수익 발표에서 수익은 13,221,339입니다. 지역별로는 Foreign이 Premium Beverage Group Inc의 주요 시장이며, 수익은 17,596,977입니다.
Hologic Incは収益を上げていますか?
no、最新の財務諸表によると、Premium Beverage Group Incの純손실は$0です。